miércoles, 7 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· December 9, 2025

Earnings live: AutoZone, Toll Brothers stocks fall, Campbell's sales decline

View original at finance.yahoo.com
Earnings live: AutoZone, Toll Brothers stocks fall, Campbell's sales decline Only a handful of major companies have yet to report their results for the last quarter, and AI leader Oracle (ORCL) is one of them…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Consumers remain intentional in shopping behaviors

    80% confidence
  • Price increases from tariffs likely to persist for a couple more quarters before normalizing, and LIFO charges to normalize in FY'26 and recover in FY'27

    80% confidence
  • 306 S&P 500 companies mentioned AI on Q3 earnings calls, a record high in 10 years

    80% confidence
  • Many consumers' wallets are pressured and seeking value

    80% confidence
  • Since Sept 30, AI-mentioning companies averaged +1% vs +0.3% for non-AI companies; since Dec 31 2024, AI-mentioning averaged +13.9% vs +5.7% non-AI

    80% confidence
  • CrowdStrike is a second/third derivative beneficiary of AI Revolution

    80% confidence
  • Housing market is soft and choppy

    80% confidence
  • AI clusters now measured in hundreds of thousands of GPUs and soon millions

    80% confidence
  • Kroger facing tougher consumer and competitive environment from Amazon grocery push and Walmart grocery share gains

    80% confidence
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Nuestra lectura de los datos ›
Señales que seguimos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,985
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,985 hechos verificados con la fuente5,351 documentos fuente archivados
Consulta estos datos → isubstrate.com